Nrf2 activation in CSCs promotes tumorigenicity, chemoresistance, and cytoprotection, while its attenuation in neurodegenerative diseases like AD increases OS and neuroinflammation [226]. Here, NFE2L2 is linked to neurodegenerative disease.